Literature DB >> 23303608

Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data.

Richard D Riley1, Iram Kauser, Martin Bland, Lutgarde Thijs, Jan A Staessen, Jiguang Wang, Francois Gueyffier, Jonathan J Deeks.   

Abstract

We describe methods for meta-analysis of randomised trials where a continuous outcome is of interest, such as blood pressure, recorded at both baseline (pre treatment) and follow-up (post treatment). We used four examples for illustration, covering situations with and without individual participant data (IPD) and with and without baseline imbalance between treatment groups in each trial. Given IPD, meta-analysts can choose to synthesise treatment effect estimates derived using analysis of covariance (ANCOVA), a regression of just final scores, or a regression of the change scores. When there is baseline balance in each trial, treatment effect estimates derived using ANCOVA are more precise and thus preferred. However, we show that meta-analysis results for the summary treatment effect are similar regardless of the approach taken. Thus, without IPD, if trials are balanced, reviewers can happily utilise treatment effect estimates derived from any of the approaches. However, when some trials have baseline imbalance, meta-analysts should use treatment effect estimates derived from ANCOVA, as this adjusts for imbalance and accounts for the correlation between baseline and follow-up; we show that the other approaches can give substantially different meta-analysis results. Without IPD and with unavailable ANCOVA estimates, reviewers should limit meta-analyses to those trials with baseline balance. Trowman's method to adjust for baseline imbalance without IPD performs poorly in our examples and so is not recommended. Finally, we extend the ANCOVA model to estimate the interaction between treatment effect and baseline values and compare options for estimating this interaction given only aggregate data.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303608     DOI: 10.1002/sim.5726

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  42 in total

Review 1.  Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; David Peick Sonne; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2016-10-17

2.  Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis.

Authors:  Mark Rodgers; David Marshall; Mark Simmonds; Ann Le Couteur; Mousumi Biswas; Kath Wright; Dheeraj Rai; Stephen Palmer; Lesley Stewart; Robert Hodgson
Journal:  Health Technol Assess       Date:  2020-07       Impact factor: 4.014

3.  Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.

Authors:  Mariann Gyöngyösi; Wojciech Wojakowski; Patricia Lemarchand; Ketil Lunde; Michal Tendera; Jozef Bartunek; Eduardo Marban; Birgit Assmus; Timothy D Henry; Jay H Traverse; Lemuel A Moyé; Daniel Sürder; Roberto Corti; Heikki Huikuri; Johanna Miettinen; Jochen Wöhrle; Slobodan Obradovic; Jérome Roncalli; Konstantinos Malliaras; Evgeny Pokushalov; Alexander Romanov; Jens Kastrup; Martin W Bergmann; Douwe E Atsma; Axel Diederichsen; Istvan Edes; Imre Benedek; Theodora Benedek; Hristo Pejkov; Noemi Nyolczas; Noemi Pavo; Jutta Bergler-Klein; Imre J Pavo; Christer Sylven; Sergio Berti; Eliano P Navarese; Gerald Maurer
Journal:  Circ Res       Date:  2015-02-19       Impact factor: 17.367

Review 4.  Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Jesper Krogh; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2016-04-21

5.  A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.

Authors:  Yongxing Xu; Guolei Yang; Xiaowen Zuo; Jianjun Gao; Huaping Jia; Enhong Han; Juan Liu; Yan Wang; Hong Yan
Journal:  Int Urol Nephrol       Date:  2021-03-29       Impact factor: 2.370

Review 6.  Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials.

Authors: 
Journal:  BMJ       Date:  2017-07-19

Review 7.  Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data.

Authors:  Louise A Beveridge; Allan D Struthers; Faisel Khan; Rolf Jorde; Robert Scragg; Helen M Macdonald; Jessica A Alvarez; Rebecca S Boxer; Andrea Dalbeni; Adam D Gepner; Nicole M Isbel; Thomas Larsen; Jitender Nagpal; William G Petchey; Hans Stricker; Franziska Strobel; Vin Tangpricha; Laura Toxqui; M Pilar Vaquero; Louise Wamberg; Armin Zittermann; Miles D Witham
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

8.  Intensive behavioural interventions based on applied behaviour analysis for young children with autism: An international collaborative individual participant data meta-analysis.

Authors:  Mark Rodgers; Mark Simmonds; David Marshall; Robert Hodgson; Lesley A Stewart; Dheeraj Rai; Kath Wright; Esther Ben-Itzchak; Svein Eikeseth; Sigmund Eldevik; Hanna Kovshoff; Iliana Magiati; Lisa A Osborne; Phil Reed; Giacomo Vivanti; Ditza Zachor; Ann Le Couteur
Journal:  Autism       Date:  2021-01-22

9.  Digital interventions in mental health: evidence syntheses and economic modelling.

Authors:  Lina Gega; Dina Jankovic; Pedro Saramago; David Marshall; Sarah Dawson; Sally Brabyn; Georgios F Nikolaidis; Hollie Melton; Rachel Churchill; Laura Bojke
Journal:  Health Technol Assess       Date:  2022-01       Impact factor: 4.014

Review 10.  Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; David P Sonne; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.